Lilly’s $400 Billion Surge Reshapes Big Pharma, Rally
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Pinpoint root causes, such as leakage or overspending, then implement targeted adjustments to regain monthly balance.
24,154 articlesEli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
A new wave of defense investing is shifting capital away from traditional U.S. contractors toward allied and private ...
As the cost of nursing-home care climbs past six figures annually, medicare won’t touch long-term care costs, forcing...
A convicted money launderer allegedly routed about $290,000 in crypto after a court ordered asset forfeiture, highlig...
Eli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
Global stablecoins have surged to hundreds of billions in circulation. Analysts warn the next currency crisis could t...
In 2025, the U.S. minted 441,000 new millionaires as the median American wealth contracted, underscoring a split econ...
Hyperion, a public hyperliquid treasury firm, announces a 500,000 HYPE token deal with Skew under a HAUS agreement, e...
Top tech leaders warn that giving AI labs access to sensitive business data may erode competitive advantages. The iss...
Dream Finders Homes expands its leadership with Steve Fischer, a banking veteran, joining the board and audit committ...
As AI spending shifts from hype to heavy borrowing, Goldman Sachs warns AI's debt tsunami may tighten credit markets....
New York billionaire Bill Ackman launches a $260 million brain research center on the Upper West Side after a family ...